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Mapping biocapital: new frontiers
of bioprospecting
Sarah Franklin
BIOS Centre, Department of Sociology, London School of Economics
When nature goes public: the making and unmaking of bioprospecting in Mexico. By Cori
Hayden. Princeton: Princeton University Press. 2003. 312 pp. $57.50 cloth; $18.95 paper. ISBN 0 691
09556 6, cloth; 0 691 09557 4 paper.
Trading the genome: investigating the commodification of bio-information. By Bronwyn Parry.
New York: Columbia University Press. 2004. 352 pp. $41.50 cloth. ISBN 0 231 12174 1.
In the context of increasing attention by world leaders to 'debt for equity' exchanges,
and economic restructuring that will both repair and redress the increasing
stratification of world trade, two questions become especially prominent: how can
past exploitations be repaid, and how can their reproduction be prevented in the
future? As argued in a recent Channel Four documentary, 'The empire pays back', a
considerable proportion of the wealth and wealth accumulating enterprises which
account for the global economic privilege enjoyed by modern nations such as Britain
derive, historically, from vast appropriations of resources, often from tropical, colonial
territories. A major worry in the context of the new 'bio-economies' of the post-
genomic 'race' to gain global market shares in new industries such as recombinant DNA
technologies is whether yet another chapter in the 'voyages of discovery' genre is
already under way.
These themes have been explored at a very general level in popular recent books
such as Patricia Fara's Sex, botany and empire, which revisits the work of scientists
such as Joseph Banks as essentially entrepreneurial.1 Similarly, Richard Drayton's
historical account of what he names the 'agrarian view of empire' demonstrates the
often under-appreciated significance of agricultural technology and engineering to
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early definitions of 'bio-wealth'.2 These accounts, alongside Londa Schiebinger's Plants
and empire,3 chart a kind of 'hidden history' of resource extraction, often described as
'bioprospecting'.
It is therefore highly significant that Bronwyn Parry's Trading the genome and Cori
Hayden's Whben nature goespublic bring the debate about biological extraction into the
contemporary frame, through detailed empirical studies of how new 'biologicals' are
being stabilized, denominated, stored, accumulated, distributed and turned into new
forms of property. Indeed, if one of the most important contemporary questions of
political geography is that of how the biological is being given new form, then these
two books are critical places to look both for how to research this question and, in part,
for how to answer it.
Cori Hayden's anthropological monograph takes us on a tour of Mexico, where for
18 months she conducted ethnographic fieldwork in the nature-culture of the new
biologicals, that is, in pursuit of patentable biodiversity, or commercially viable
biological action, or simply indigenous biowealth. Following this ethno-botanical
action around takes us to unexpected places - to remote markets in Northern Mexico
filled with savvy vendors of dried yerbas - yerba de la vibora, yerba del zorillo, yerba
del conejo. Frequently on the move, Hayden's research took her to artisans' collectives
where the agave cactus is pit-roasted to make mescal, and up dry arroyos to hidden
ranch-houses in old copper mines to find the old and new natures being forged out of
indigenous knowledge and native plant resources. She also spent time in museums and
in laboratories, and went shopping at traditional Mexican markets, as well as collecting
samples along roadsides and in 'disturbed areas' burnt by forest fires, always
accompanying her ethnobotanical biologos on their quest to discover new sources of
potentially marketable biocapital. Her clippers never far from her hand, she gets all
mixed up in the complicated business of botanical bioprospecting and the elusive quest
to find 'isolated compounds that ostensibly can be shown to have discrete kinds of
efficacy' (p. 194). For Hayden, all of this movement is a crucial indicator that plant
resources must be made, as well as found: by being given new kinds of 'connection' a
bioactive plant extract can be reanimated as a commercial product.
As Hayden notes in her superb overview of debates about patenting 'life itself', these
movements and mixtures are what define the geography of bioprospecting, hybridizing
scientific and indigenous knowledges, abstract nomenclature and venture capital, and
'bioactivities' with the technologies that can extract them. After all, property is always a
mixture: a containment strategy 'sutured together', to use a phrase Hayden returns to as
a refrain throughout, out of legal entitlements, individual identities, national constitu-
tions and conceptual legacies. Property is itself the product of a paradoxical process, a
reification which must be as fluid as it must be stable - a bit like the biological itself.
The fluidity, but intractability, both of the biological and its properties and of the
power that is needed to give these a stable economic shape, is the idea that unites both
of these books, which each offer timely and insightful analyses of the contested
relationship between biological collection and its commodification. Bronwyn Parry's
economic geography of biological trade begins in the unlikely location of Frederick,
Maryland, at the Natural Products Repository of the US National Cancer Institute. Here,
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in 'a wholly unremarkable brown warehouse' in a rural backwater are stored more than
50000 different samples of plants, animals, fungi and other organisms, from whole
frozen starfish to yew leaves in what Parry calls 'a technoscientific ark'. From here she
takes us on an extraordinary tour, from the history of the New World voyages and their
mania for collection to the molecularization of the activity of bio-assays, which can now
be used to screen vast quantities of materials for their bio-activity levels at
unprecedented speed.
This tour ranges from the early 'gatherings of nature' by herbalists and apothecaries
to the New World 'voyages of discovery' and their accumulations in the form of early
biobanks such as Kew Gardens. As Parry points out, even these early biological
collections were also 'centres for calculation' in their function as classifying and
taxonomizing hubs of imperial expansion. She argues that while contemporary
collecting by museums, universities and corporate research institutes have much in
common with these legacies, they are also different, in that the role of the 'genetic
software' has come to be as important an informatic repository of biodiversity as the
sample itself, thus spawning a whole new genre of 'proxies' which are promiscuously
mobile and easy to replicate.
It is in this way, empirically and theoretically explored in both these path-breaking
books, that we see a transformation of both kind and degree in the nature of
biobanking. This, of course, has huge implications, not only because of the changes in
scale that Bronwyn Parry demonstrates in her account of how the genomes of plants,
animals and micro-organisms are now transformable and transactable in ways that were
heretofore unimaginable, but because, as she points out, biobanking is increasingly
directed at human DNA, human tissue, human embryos and human stem cells.
This means we are very much in need of the kinds of vocabulary these two books
begin to forge in what might be described as the vacuum of current public debate about
biobanking (cf. the recent anthology edited by Richard Tutton and Oonagh Corrigan4).
For Cori Hayden, following the biological action in the world of bioprospecting can
usefully be seen in terms of what she describes as 'unexpected webs of accountability'.
As both Hayden and Parry show, most of the biologically desirable resources are in the
economically deprived south, now, as in the past, the source of most of the world's
valuable 'tropilogicals'. But, as both authors also discuss in depth, the efforts made by
many countries, governments and NGOS, through conventions, treaties, corporate
policies and local governance, to benefit share are much more easily agreed in
principle than they are to carry out.
In fact, one of the most important scholarly and intellectual legacies of these two
books put together is their combined diagnosis of what is wrong with the idea of
benefit sharing, and why - despite the fact that everyone agrees with the principle of
reciprocity enshrined in documents such as the 1992 UN Convention on Biological
Diversity - there is very little evidence of actual economic result.
For Hayden, the problem is, not inaccurately, described as hedging. All of the
intentions, ethical commitments and promises are hedged with ambivalence and
uncertainty. The simple principle of taking being reciprocated by giving back becomes
so disaggregated across such complicated networks of what she calls 'multilateral
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expectations' and 'multidirectional forms of exchange' that their intentions are lost in a
miasma of dispersed responsibility and delayed obligation.
Thus, for Hayden, a key term is 'interest' - who is interested, who has an interest, and
what is biologically 'interesting'? This interest, she notes, never comes without
attachments - and it is the attachments that are the hedge, the hedging, the semi-
permeable, ubiquitous barrier that, as in Raymond Williams's famous description of
British hedgerows,5 simultaneously display and obscure the industries of rural
settlement.
For Parry, an important remedy can be found in the form of duty - both in the moral
and financial sense, indeed, where they meet. While some already powerful national
economies are in a position to capitalize on what she calls the 'brave new bio-
informational economy', others are not, and this is how age-old inequalities based on
being bio-rich and bio-poor will once again be widened through the process of 're-
mining' of the biological as the informatic. Hence, while it is reported that
pharmaceutical companies are estimated to earn between $75 and $150 billion
annually from natural materials sourced primarily from developing countries, none
of these countries has ever received any significant redistributed income from these
markets.
A duty, or levy, on all products sourced in this way of 3 to 5 per cent would clearly
reverse such a tendency, and would avoid the baroque complexity of product
traceability exhaustively documented by both of these books, and ultimately diagnosed
by them as chronically infirm. Such simple solutions are surely within reach of a society
capable of mapping the human genome and reproducing it on a CD. On the other
hand, these books both demonstrate the depth of conflict between the drive to
accumulate wealth and the desire to distribute it more equitably. Appearing at a crucial
moment when the effort to repay past debts is at a high point of public visibility, and
yet another round of 'bio-extraction' is already under way, these two books offer
invaluable perspectives that reveal the making of biowealth from the inside out.
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